Table 4.

Univariate and Multivariate survival analysis of CLDN18-ARHGAP26/6 fusion gene in TCGA and Shu cohort.

Characteristics		Univariate Analysis			Multivariate Analysis
		OR	95% CI	P-value	OR	95% CI	P-value
Age (years)	<65 vs. ≥65	1.14	0.877–0.959	0.136	1.343	1.125–1.603	0.090
Gender	Male vs. Female	1.042	0.868–1.252	0.658	0.988	0.817–1.195	0.900
Tumor location	Upper vs. Other	0.973	0.810–1.168	0.769	0.868	0.722–1.044	0.134
T stage	T2 vs. T1	3.119	0.960–10.130	0.058
	T3 vs. T1	3.953	1.253–12.470	0.019
	T4 vs. T1	6.455	2.073–20.100	0.001
N stage	N1 vs. N0	1.999	1.379–2.897	<0.001
	N2 vs. N0	2.453	1.733–3.471	<0.001
	N3 vs. N0	3.94	2.888–5.376	<0.001
TNM stage	II vs. I	1.29	0.725–2.294	0.386	1.339	0.753–2.385	0.32
	III vs. I	2.864	1.668–4.889	<0.001	3.018	1.763–5.164	<0.001
	IV vs. I	6.669	3.825–11.628	<0.001	7.155	4.083–12.538	<0.001
CLDN18-ARHGAP26/6 fusion	Positive vs. Negative	1.629	1.247–2.127	<0.001	1.365	1.031–1.809	0.03

OR, odds ratio; 95% CI, 95% confidence interval.

^*Only TNM stage entered into the Cox regression model due to the potentially confounding effect.